New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...

A phase 3 trial of Daiichi Sankyo and Merck & Co.’s HER3-directed antibody-drug conjugate (ADC) has hit its primary endpoint, ...

Researchers develop synthetic antibody that, when combined with common lung cancer drug, prevents relapse of adenocarcinoma ...

“They suspected lung cancer,” said lung cancer awareness advocate Matthew Koebbe. “We did a biopsy, and confirmed that, yes, ...

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West ...

A new Mount Sinai study published in the Journal of the National Cancer Institute on September 10, 2024, has found that ...

The FDA has approved Rybrevant plus chemotherapy in certain patients with locally advanced or metastatic non-small cell lung ...

Treatment of non-small cell lung cancer (NSCLC) depends on the stage you're in and can include chemotherapy, surgery, ...

A team of doctors and researchers have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked.

The LUNG FORCE Run/Walk provides critical funds for lifesaving lung cancer research, early detection initiatives and ...